The truncated estrogen receptor alpha variant lacking exon 5 is not involved in progesterone receptor expression in meningiomas

Journal of Steroid Biochemistry and Molecular Biology

Volumn 71, Issue 5-6, 1999, Pages 167-172

  Jacobs, H M ^a   Van Spriel, A B ^a   Koehorst, S G A ^a   Thijssen, J H H ^a   Blaauw, G ^b   Blankenstein, M A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Sittard Geleen Heerlen   (Netherlands)

Author keywords

Alternatively spliced estrogen receptor; Meningioma; Progesterone receptor expression

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ARTICLE; BREAST CANCER; ENZYME IMMUNOASSAY; GENE ACTIVATION; HUMAN; HUMAN TISSUE; LIGAND BINDING; MENINGIOMA; SEQUENCE ANALYSIS;

BLOTTING, SOUTHERN; BREAST NEOPLASMS; CLONING, MOLECULAR; ESTROGEN RECEPTOR ALPHA; EXONS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MENINGEAL NEOPLASMS; MENINGIOMA; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; SEQUENCE DELETION; TRANS-ACTIVATION (GENETICS); TUMOR CELLS, CULTURED;

EID: 0033492438     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(99)00141-7     Document Type: Article

References (25)

1. Blankenstein M.A., Blaauw G., Lamberts S.W.J., Mulder E. Presence of progesterone receptors and absence of oestrogen receptors in human intracranial meningioma cytosols. Eur. J. Cancer Clin. Oncol. 19:1983;365-370.
2. Blankenstein M.A., Berns P.M., Blaauw G., Mulder E., Thijssen J.H.H. Search for estrogen receptors in human meningioma tissue sections with a monoclonal antibody against the human estrogen receptor. Cancer Res. 46:1986;4268s-4270s.
3. Koehorst S.G.A., Jacobs H.M., Thijssen J.H.H., Blankenstein M.A. Detection of an oestrogen receptor-like protein in human meningiomas by band shift assay using a synthetic oestrogen responsive element (ERE). Br. J. Cancer. 68:1993;290-294.
4. Fuqua S.A.W., Falette N.F., McGuire W.L. Sensitive detection of estrogen receptor RNA by polymerase chain reaction assay. J. Natl. Cancer Inst. 82:1990;858-861.
5. Koehorst S.G.A., Jacobs H.M., Thijssen J.H.H., Blankenstein M.A. Wild type and alternatively spliced estrogen receptor messenger RNA in human meningioma tissue and MCF7 breast cancer cells. J. Steroid Biochem. Molec. Biol. 45:1993;227-233.
6. Koehorst S.G.A., Cox J.J., Donker G.H., Lopes da Silva S., Burbach J.P.H., Thijssen J.H.H., Blankenstein M.A. Functional analysis of an alternatively spliced estrogen receptor lacking exon 4 isolated from MCF7 breast cancer cells and meningioma tissue. Mol. Cell. Endocrinol. 101:1994;237-245.
7. McGuire W.L., Chamness G.C., Fuqua S.A.W. Estrogen receptor variants in clinical breast cancer. Molec. Endocr. 5:1991;1571-1577.
8. Fuqua S.A.W., Fitzgerald S.D., Chamness G.C., Tandon A.K., McDonell D.P., Nawaz Z., O'Malley B.W., McGuire W.L. Variant human breast tumor estrogen receptor with constitutive transcriptional activity. Cancer Res. 51:1991;105-109.
9. Fuqua S.A.W., Wolf D.W. Molecular aspects of estrogen receptor variants in breast cancer. Breast Cancer Res. Treat. 35:1995;233-241.
10. Blankenstein M.A., van der Meulen-Dijk C., Thijssen J.H.H. Assay of oestrogen and progestin receptors in human meningioma cytosols using immunological methods. Clin. Chem. Acta. 165:1987;189-195.
11. Chomczynski P., Sacchi N. Single step method of RNA isolation by acid guanidium thiocyanate phenol chloroform mixture. Anal. Biochem. 162:1987;156-159.
12. Greene G.L., Gilna P., Waterfield M., Baker A., Hort Y., Shine J. Sequence and expression of human estrogen receptor complementary DNA. Science. 231:1986;1150-1153.
13. Wang Y., Miksicek R.J. Identification of a dominant negative form of the human estrogen receptor. Mol. Endocrinol. 5:1991;1707-1715.
14. Pfeffer U., Fecarotta E., Castagnetta L., Vidali G. Estrogen receptor variant messenger RNA lacking exon 4 in estrogen - responsive human breast cancer cell lines. Cancer Res. 53:1993;741-743.
15. Fuqua S.A.W., Fitzgerald S.D., Allred D.G., Elledge R.M., Nawaz Z., McDonell D.P., O'Malley B.W., Greene G.I., McGuire W.L. Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors. Cancer Res. 52:1992;483-486.
16. Madsen M.W., Reiter B.E., Larsen S.S., Briand P., Lykkesfeldt A.E. Estrogen receptor messenger mRNA splice variants are not involved in antiestrogen resistance in sublines of MCF7 human breast cancer cells. Cancer Res. 57:1997;585-589.
17. Rice L.W., Jazaeri A.A., Shupnik M.A. Estrogen receptor MRNA splice variants in pre- and postmenopausal human endometrium and endometrial carcinoma. Gynec. Oncol. 65:1997;149-157.
18. Pfeffer U., Fecarotta E., Vidali G. Coexpression of multiple estrogen receptor variant messenger RNAs in normal and neoplastic breast tissues and in MCF-7 cells. Cancer Res. 55:1995;2158-2165.
19. Zhang Q.-X., Borg A., Fuqua S.A.W. An exon 5 deletion variant of the estrogen receptor frequently coexpressed with wild-type estrogen receptor in human breast cancer. Cancer Res. 53:1993;5882-5884.
20. Castles C.G., Fuqua S.A.W., Klotz D.M., Hill S.M. Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line. Cancer Res. 53:1993;5934-5939.
21. Daffada A.A.I., Johnston S.R.D., Nicholls J., Dowsett M. Detection of wild type and exon 5 - deleted splice variant oestrogen receptor (ER) mRNA in ER-positive and negative breast cancer cell lines by reverse transcription/polymerase chain reaction. J. Molec. Endocrinol. 13:1994;265-273.
22. Speirs V., Boyle-Walsh E., Fraser W.D. Constitutive co-expression of estrogen and progesterone receptor MRNA in human meningiomas by RT-PCR and response of in vitro cell cultures to steroid hormones. Int. J. Cancer. 72:1997;714-719.
23. Magrassi L., Butti G., Silini E., Bona F., Paoletti P., Milanesi G. The expression of genes of the steroid-receptor superfamily in central nervous system tumors. Anticancer Res. 13:1993;859-866.
24. Rea D., Parker M.G. Effect of an exon 5 variant of the estrogen receptor in MCF-7 breast cancer cells. Cancer Res. 56:1996;1556-1563.
25. Ohlsson H., Lykkesveldt A.E., Madsen M.W., Briand P. The estrogen receptor variant lacking exon 5 has dominant negative activity in human breast epithelial cell line HMT-3522Sl. Cancer Res. 58:1998;4264-4268.